Introduction
The microsomal monooxygenase system of liver catalyses the metabolism of a wide variety of en dogenous compounds including drugs, insecticides and carcinogens. To investigate monooxygenase systems, sensitive methods for the determ ination of enzyme activity are necessary.
DeLuca et al. (1986) reported the development of a direct fluorometric assay for a cytochrome P450 catalyzed reaction (O-deethylation), which is based on the use of 7-ethoxy-4-trifluoromethylcoumarin (EFC), an analog of the widely em ployed substrate 7-ethoxycoumarin (7-EC) (Ull rich and Weber, 1972) . According to DeLuca et al. the use of 7-EC suffers from the drawback that the excitation and emission maxima of this sub strate (340 and 450 nm respectively) correspond to
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NADPH, limiting the sensitivity of the direct 7-EC-assay. The assay using EFC as substrate does not have this disadvantage but the the low solubil ity of EFC in buffer requires the addition of 0.2% DMSO, which inhibits the reaction by about 10% (Buters et al., 1993) .
We report here the development and characteri sation of a direct fluorometric assay for a cyto chrome P450 catalyzed O-demethylation based on the use of 3-chloro-7-methoxy-4-methylcoumarin (CMMC) (Fig. 1 ). This assay exhibits the advan tages of the direct EFC-test. Moreover, the sub strate used in our assay does not require the addi tion of DMSO due to a better solubility in buffer.
Materials and Methods

Materials
3-chloro-7-hydroxy-4-methylcoumarin (CHM C) was obtained from Sigma-Aldrich Chemie Gm bH (Steinheim, Germany). 3-chloro-7-methoxy-4-methylcoumarin was synthesized from CHMC with the aid of dimethylsulfate. 3-methylcholanthrene (MC) and m etyrapone (2-methyl-l,2-di- 3-pyridyl-l-propanone), chlorzoxazone (5-chloro-2-hydroxybenzoxazole) and a-naphthoflavone (7,8-benzoflavone) were obtained from Sigma (Deisenhofen, Germany), phenobarbital (Lumi nal1 *) (PB) from Bayer (Leverkusen, Germany). The sodium salts of NAD H and NADPH were purchased from Boehringer Mannheim (M ann heim, Germany). The other commercial products were from Merck, (Darm stadt, Germany). All chemicals and biochemical used were of the high est grade available.
Chrom atography
Thin-layer chromatography was perform ed on precoated TLC silica gel 60 plates (20 x 20 cm, thickness 0.25 mm) from Merck (Darm stadt, G er many) using the solvent system toluene/acetone (9:1, v/v). Developed plates were examined for fluorescence under the longwave ultraviolet light (366 nm) of an UV lamp (MinUVIS 13100) from Desaga (Heidelberg, Germany).
High-performance liquid chromatography was carried out on a HPLC system consisting of a Pharmacia LKB pump 2249 (Pharmacia LKB Bio technology, Freiburg, Germany), a model 7125 sy ringe loading sample injector (Rheodyne, Cotati, California, USA) and a 250 x 8 mm column pre packed with nucleosil C 18, 5 [im particle size (Grom, Herrenberg-Kayth, Germany). The elu tion was perform ed with a mobile phase methanol/ water (6:4, v/v). Detection was carried out with a Model RF-535 fluorescence HPLC monitor (Shimadzu Corporation, Kyoto, Japan). The excitation wavelength was 380 nm, the detection wavelength was 480 nm. The fluorescence detector was con nected with a data processor, Chrom atopac C-R6A (Shimadzu, Corporation, Kyoto, Japan).
Fluorometry
Fluorescence m easurements were perform ed with a "Fluorolog F212" spectrofluorom eter (Spex Industries Inc., Grasbrunn, Germany).
The fluorescence activation and emission spectra were recorded in a quartz cuvette with a 10 mm light path, Type 104 F-QS; the enzyme activities were assayed using a quartz cuvette with a 10 mm light path Type 119 000 F QS (Hellma GmbH & Co, Mülheim, Germany).
Mass spectrometry
Mass spectrometry was perform ed using a mass spectrometer "SSQ 7000" (Finnigan MAT). Frag mentation patterns resulting from electron impact of the main metabolite and the second minor m e tabolite have been determ ined.
Animals and enzym e induction
Male Sprague-Dawley rats, weighing 250-300 g, were purchased from Charles River (Sulzfeld, Germany). The animals were kept under standard ized conditions with free access to pellet need and tap water.
Effects o f pretreatment with phenobarbital or 3-methylcholanthrene in liver microsomes: One group of animals was induced with PB by replac ing the drinking water by a solution of PB (0.1% in tap water) for 6 days prior to sacrifice. A second group of rats was given MC (20 mg/kg body weight in corn oil) intraperitoneally once each day for 3 days.
Preparation o f microsomes
Rats were sacrificed by placing them into a car bon dioxide atmosphere. Immediately after death livers were excised.
All steps to prepare the microsomal fraction were carried out at 0 -4 °C. Livers were homoge nized in 0.25 m sucrose (4 ml/g liver) in a Waring blendor model 32 BL 80 (Waring products divi sion, Dynamics C orporation of America, New H artfort, USA). The hom ogenate was centrifuged at 13000xg for 30 min. The microsomal fraction was obtained by centrifuging the 13000xg super natant for 60 min at 100000xg. The pellet was re suspended in 0.25 m sucrose and centrifuged again for 60 min at lOOOOOxg. The pellet was resus pended in 0.25 m sucrose and stored as 1.2 ml ali quots at -7 0 °C.
Protein concentration was determined accord ing to Lowry et al. (1951) using bovine serum albu min as a standard.
Test procedure
For measuring microsomal CMMC O-demethylase activity a standard incubation mixture was prepared by adding 2.79 ml of 3-chloro-7-methoxy 
Product identification
For product identification by means of thinlayer chromatography and high-performance li quid chromatography the following incubation mixture was used: 95.0 ml of CMMC (2 • 10~5 m in 0.05 m Tris/HCl buffer, pH 7.6), 1.0 ml of MgCl2 (10-1 m ), 1.5 ml of liver microsomes from PB-induced rats (corresponding to about 1.5 mg protein, in 0.25 m saccharose), 3.3 ml of NADPH (10-3 m in 0.05 m Tris/HCl).
Six incubation mixtures were incubated, one of which was drawn up as a blank. To the latter incu bation mixture 50 ml of chloroform was added and stirred for 30 min before the addition of NADPH. The procedure of the following steps was identical for all incubation mixtures. The incubation mix tures were incubated by shaking for 30 min in a water bath at 30°. With the exception of the blank, the reaction of each incubation mixture (sample) was term inated by the addition of 50 ml of chloro form. The samples were extracted 3 times with 50-ml portions of chloroform. The extract of the blank was reduced by evaporation to about 0.5 ml, the combined extracts of the other samples ("probes") were also restricted to about 0.5 ml. The solutions were applied in lines (samples: 10.5 cm; blank: 2.5 cm in length) to a thin layer plate and chromatographed 2 times in the solvent sys tem toluene/acetone (9:1, v/v). In the case of the "samples", examination of the TLC plate under UV-light revealed in addition to the substrate band a second band, which comigrated with an au thentic sample of CHMC.
A silica gel band, 1.5 cm in width, was scraped off the plate from the dotting line to the solvent front in the direction of the solvent flow ("cross section band"). The rest of the band, which comi grated with CHMC ("product band") was also scraped off in order to determ ine by HPLC whether this band represents a single substance. The silica gel portions were extracted twice with 2.5-ml portions of chloroform; the extracts were filtered through a glass fibre disc (APFF-Type F, Millipore, Bedford, Mass., USA). Before sub jecting the samples to separation by HPLC the filtrates were evaporated, and the residues were redissolved each in 1 ml of methanol. The solu tions were injected in 100 |^1 portions and chro matographed at a flow rate of 2 ml/min.
Concerning the HPLC chromatograms of the "product band", the fractions with the retention time of an authentic sample 3-chloro-7-hydroxy-4-methylcoumarin as well as the fractions of another metabolite with a retention time of 8.8 min were combined and evaporated to dryness. The residues were dissolved in 0.05 m Tris/HCl (pH 7.6) and the solutions were subjected to fluorescence spectros copy.
With an other set of incubations chrom ato graphic separations were carried out in the same way. The HPLC-fractions of the two substances were also combined and evaporated to dryness. The residues were analysed by mass spectrometry.
Results
Fluorescence spectroscopy
The excitation spectra and the fluorescence emission spectra of CMMC and of CHMC (10-5 m in 0.05 m Tris/HCl buffer, p.H. 7.6) are shown in Fig. 2 . The emission spectra were recorded at an excitation wavelength of 330 nm. If the excitation wavelength is adjusted to 380 nm the fluorescence of CHMC, m easured at 480 nm is -compared with that of CMMC -enhanced by the factor of 3 • 103. The only cofactor which might, regarding its ex citation and emission maximum (380 nm and 470 nm, respectively) influence the measurement of fluorescence in the test is NADPH. Compared with the substrate, NAD PH was added to the incu bation mixture in a molar ratio of 1 : 1.5. At the wavelengths of 380 nm and 480 nm the interfering fluorescence of NADPH is in this concentration about 1000-fold lower than that of CHMC.
Incubation experiments with rat liver microsom es
Identification o f the products: For product iden tification by means of chromatography, CMMC was incubated as described above with liver micro somes from phenobarbital induced rats. The ex tracts of the incubation mixtures were analysed by TLC using the mobile phase toluene/acetone (9:1, v/v). In comparison with the controls, a new fluo rescent line with the R F-value of authentic CHMC (R f = 0.45) was seen under 366 nm illumination. This band contained -as shown by HPLC -be sides the main product a further metabolite. The identification of the main product (tR = 11.2-11.3) as CHMC was carried out by fluorescence spectroscopy and mass spectrometry: The main metabolite showed the same excitation and fluo rescence spectra as CHMC exhibiting maxima at XA -340 nm and X .F = 475 nm.
The mass spectrum was identical with that of the authentic substance. As in the spectrum of authen tic CHMC the molecular ion (m /z 210) forms the base peak and a strong [M-CO]+ ion, 28 mass units lower, is also present (m /z 182). An ion at m /z 154 and another ion at m /z 147 is formed from the [M-CO]+ ion by loss of CO and Cl respectively. A loss of Cl from the ion at m /z 154 forms an ion peak at m /z 119 and a loss of CO from this ion forms a peak at m/z 91.
The minor metabolite (tR = 8.7-8.9) exhibited (in 0.05 m Tris/HCl buffer. pH 7.6) an excitation maximum XA at 338 nm and a fluorescence emis sion maximum at 422 nm. The mass spectrum of the substance showed that this m etabolite is a hydroxylated product of the substrate CMMC. The molecular ion (m/z 240) forms the base peak in the spectrum of this minor m etabolite and a [M-CO]+ ion (m /z 212) is also present. Loss of Cl from this ion intervenes to provide an ion at m /z 177. Otherwise, loss of Cl from the molecular ion forms an ion at m /z 205. Loss of CO from this ion also forms the ion at m /z 177.
In order to estimate the fluorescence intensity of the minor metabolite in comparison with that of CHMC, we collected both metabolites, employing three different separations on the HPLC-column.The fractions were evaporated, the residues dissolved in 0.05 m Tris/HCl, pH 7.6. Exited at 380 nm, the fluorescence intensity of the minor m etabolite, measured at 480 nm, amounted only to 1.21 ± 0.28% to that of CHMC.
Direct fluorom etric assay: When CMMC was in cubated with liver microsomes of untreated rats, a continuous increase of fluorescence could be m ea sured as soon as the reaction has been initiated by the addition of NADPH. The O-demethylation of the substrate by liver microsomes from untreated, PB-and M C-pretreated rats displayed a pH-optimum between 7.4 and 7.6. The reaction proceeded linearly at least up to 0.2 mg/ml of microsomal protein and for about 10 min (see Fig. 3 ). Under the conditions described above, the mean O-demethylase activity was calculated to be 1.5 ± 0.13 nmol CHMC/min • mg protein. The specific activities found in liver microsomes of rats pre treated with PB and MC were 1.9 ±0.52 and 1.3 ± 0.11 nmol CHMC/min • mg protein. Hence, pre treatm ent of rats with phenobarbital increased slightly the specific demethylation activity. But, the m etabolic rate using microsomes of rats pre- treated with MC were less than those observed for constitutive microsomal activities.
Cofactor requirements:
The enzymatic genera tion of CHMC was oxygen-dependant: This could be shown by gassing the incubation mixture (-NADPH) with argon prior to the addition of NADPH. There was a strict requirem ent for NADPH. The addition of N AD H instead of NAD PH as electron donor resulted in a loss of enzyme activity which was found to be only 7% (PB -pretreated rats) and 12% (M C-pretreated rats). Also Mg2+ had a significant effect on the Odealkylation activity (Table I ). The fluorescence of NAD PH did not interfere with the test.
Effect o f various inhibitors on the O-dem ethyla tion o f CM M C by rat liver microsomes: CM M C
O-demethylation responded to PB but not to MC induction. To gain more insight into the cyto chrome P450 isoenzymes catalysing O-dem ethyla tion of CMMC, inhibition studies were performed in liver microsomes of untreated rats and rats pretreated with PB (see Table II ). M etyrapone (2-methyl-l,2-di-3-pyridyl-l-propanone) inhibited the 3-chloro-7-methoxy-4-methylcoumarin O-de methylation in PB induced microsomes (62%) to a greater extend than in uninduced microsomes (28%). Chlorzoxazone inhibited the metabolic generation of 3-chloro-7-hydroxy-4-methylcoumarin in microsomes of PB-induced rats by 61 % and in microsomes of uninduced rats by 28%. The clas sic inhibitor of the cytochrome 1A family (P450 1A1 and 1A2), a-naphthoflavone, (Murray and Reidy, 1990; Boobis et al., 1990; Guengerich, 1991) inhibited the reaction neither in PB induced nor in uninduced microsomes.
Assay kinetics: The enzyme kinetics of CMMC O-demethylation were determ ined using liver microsomes from -untreated rats and PB-induced rats. Representative examples of Hanes and Eadie-Hofstee transform ation are shown in Fig. 4 . In the Hanes and Eadie-Hofstee plots of the CMMC O-dem ethylation by microsomes of PBtreated rats, more than one phase became appar ent. We conclude that more than one isoenzyme metabolized the substrate. V^ax and K m were cal culated from a linear regression equation fitted to the linear part of the Hanes transform ed data. As in the case of deethylation of EFC (Buters et al., 1993) this approach yields hybrid parameters. Lin ear regression analysis of the data presented gives Table I . C ofactor re q u irem en t for th e O -dem eth y latio n of 3-chloro-7-m ethoxy-4-m ethylcoum arin by liver m icro som es of u n treated rats and rats p re tre a te d with p h en o b arb ital and 3-m ethylcholanthrene, respectively. 
Discussion
We have examined the utility of the coumarin derivative, CMMC, in the determ ination of m o nooxygenase activities in liver microsomes of un treated, PB-and M C-treated rats. We were able to describe a direct test. Cofactor requirem ents and inhibitors point to the involvement of cytochrome P450 as terminal oxidase.
Besides the demethylation product CHM C only one further metabolite was found to be formed during the incubations. Under assay conditions (pH 7.6), the fluorescence of this substance was only about 1 % of the fluorescence of the main product. We found a high fluorescence yield of CHMC relative to CMMC at an exitation wave length and a fluorescence/emission wave length of 380 nm and 480 nm respectively. In rat liver micro somes the O-demethylation proceeds linearly with protein concentration and time. We found a very low back ground drift (Fig. 3) and a high level of activity with uninduced samples. So, we described here a direct microsomal test, in which the microsomal activity can be measured without sample clean up, which has an advantage over the procedure, described by De Luca et al. (1986) . Contrary to EFC, CMMC can be dissolved in buffer without requiring the addition of DMSO, which inhibits the reaction. We obtained evidence that more than one isoenzyme m etabolized 3-chloro-7-methoxy-4-methylcoumarin. The de methylation of 3-chloro-7-methoxy-4-methylcoumarin was moderately induced by PB but not by MC. The isoenzymes induced by PB had low affin ity relative to control. DeLuca et al. (1986) exam ined the induction of EFC O-deethylase with PB and MC. While both reagents clearly induced EFC O-deethylase activity the isoenzymes induced by MC appeared to have high affinity for EFC whereas those induced by PB had -comparable with our results -low affinity relative to control.
Metyrapone, one of the most frequently em ployed P450 inhibitors, which is known as an in hibitor of phenobarbital induced monooxygenases, inhibited the CMMC O-demethylase activity in microsomes of rats pretreated with PB and un treated rats by 62% and 28%, respectively. Chlor zoxazone, which is considerd to be a specific sub strate of P450 2E1 (Peter et al., 1990) inhibited CMMC O-demethylation in PB-induced micro somes by 61% and in uninduced microsomes by 28%. Reactions catalysed by cytochrome P450 2E1 often show cross reactivity with P450 1A2 (Raucy et al., 1989; Buters et al., 1993; Yamazaki et al., 1996) . But, a-naphthoflavone, an inhibitor of the cytochrome 1A family (P450 1A1 and 1A2) (Murray and Reidy, 1990; Boobis et al., 1990; Guengerich, 1991) did not inhibit the metabolic generation of CHMC in untreated rats and rats pretreated with phenobarbital. No inhibition by anaphthoflavone in uninduced rat and human livers was also reported with regard to the O-deethylation of 7-EC (Kremers et al., Buters et al., 1993) , which has shown to be catalysed by cyto chromes P450 2E1 and 1A2 in microsomes of rat liver (Ryan and Levin, 1990 ) and human liver (Ya mazaki et al., 1996) .
Due to the inhibition by chlorzoxazone we sup pose that cytochrome P450 2E1 is one of the en zymes involved in the demethylation of CMMC. A participation of P450 1A2 in this reaction can not be excluded.
There are several similar direct fluorometric as says for the determination of cytochrome P450 en zyme activity available, utilising in addition to 7-ethoxycoumarin (Ullrich and Weber, 1972) , alkoxy resorufins (Mayer et al., 1990), 3-cyano-7-ethoxycoumarin (White, 1988) and scoparone (Müller-Enoch et al., 1981) as substrates. The assay de scribed by DeLuca et al. (1986) , using the substrate 7-ethoxy-4-trifluoromethylcoumarin offers as con firmed by Buters et al. (1993) some distinct advan tages over these assays. The assay described here, which exhibits the advantages of the EFC-test, has the further advantage that the substrate -in the concentration required -does not need the addi tion of a solubiliser due to a higher solubility in buffer. CMMC is metabolised mainly to CHMC. The fluorescence of a minor metabolite, a hydroxylated derivative of the substrate, under the condi tions of the test, accounted for only about 1 % of the fluorescence of the main product. Compared to the EFC-test, the amount of microsomal pro-
